Latest Featured Products

Let's dive into data integrity in the workplace. It is important that there is an understanding of how data integrity is defined when considering establishment of a compliant working environment and process.

Traditionally identifying the identity of frost covered racks of 2D barcoded tubes taken from low temperature storage has been a time-consuming and error prone process. Drawing upon proprietary Radio Frequency Identification (RFID) tagging technology – the RITrack Mirage from Ziath can reliably read 2D barcoded racks covered in ice and with racks taken directly from vapour-phase liquid nitrogen storage.

Design Hub is the all-in-one DMTA platform that effectively manages drug design projects from idea creation to implementation.

Discover ioSensory Neurons, precision reprogrammed human iPSC-derived nociceptors from bit.bio. Don’t settle for non-human in vitro models or long, complex differentiation protocols that require toxic reagents. Start running reliable nociception assays with ioSensory Neurons today.

Label-free biosensor technologies have emerged as a promising approach to identify high-value hits with a strong likelihood of success as a therapeutic. Unlike traditional approaches of drug discovery, they are fast, sensitive, and come with improved success rates towards high-value drug candidates.

Designed with sustainability in mind, the Avio® 220 Max is a compact, hybrid simultaneous ICP-OES with multiple waste-reducing technologies.

From the quickest start-up time on the market to reduced argon consumption, the Avio 220 Max is ideal for labs with low-to-medium throughput requirements.

From raw data to report, simplify your NGS and CGH data analysis and variant interpretation with integrated bioinformatics for your translational research.

The Revio system adds affordability, high throughput, and ease of use to a foundation of long
reads, exceptional accuracy, and direct methylation detection. Get reads that are tens of
kilobases in length with >Q30 scores and complete phased genomes for <$1,000, all with 50%
fewer consumables.

CARNK cell therapies are novel therapeutic options developed with the aim to overcome some limitations of CART cell therapies, such as therapy induced side effects.

Mix and match up to 21 protein assays with 99% combinability. Each and every assay is transparently validated to the highest standards and you can be fully confident that whatever combination of assays you select will work together and deliver high quality data with excellent specificity, sensitivity, and dynamic range